Supreme Court backs FTC in 'pay-for-delay' case re: Generic Drugs

  1. 2
    The U.S. Supreme Court ruled today that the Federal Trade Commission can proceed with its “pay-for-delay” case, which argues that pharmaceutical manufacturers illegally restrict competition by reaching deals with generic drug companies to keep cheaper versions of drugs off the market.

    The commission had brought a case which alleged that the decision of Solvay Pharmaceuticals, a subsidiary of Abbott Laboratories, to pay competing drug companies in exchange for an agreement not to market generic versions of a testosterone drug was illegal. ...

    Read more: BREAKING: Supreme Court backs FTC in 'pay-for-delay' case | Modern Healthcare http://www.modernhealthcare.com/arti...#ixzz2WUFD1Xf1
    ?trk=tynt
    CrufflerJJ and aknottedyarn like this.

    Get the hottest topics every week!

    Subscribe to our free Nursing Insights newsletter.

  2. 3 Comments...

  3. 4
    and the exclusive for profit model of health care encourages this...
    fortunately we are talking here about testosterone and not 5FU, which also has a new, more expensive, non-generic, option.
  4. 5
    Quote from tewdles
    and the exclusive for profit model of health care encourages this...
    fortunately we are talking here about testosterone and not 5FU, which also has a new, more expensive, non-generic, option.

    Big Pharma...bless their greedy little hearts. So good at re-inventing the wheel.
    Last edit by OCNRN63 on Jun 17, '13
    tewdles, Esme12, aknottedyarn, and 2 others like this.
  5. 5
    Interesting that the drug that got the attention was testosterone, not anti-cancer drugs or anti-hypertensives.

    Facts like these spark my "feminazi" actions.
    StNeotser, tewdles, wooh, and 2 others like this.


Nursing Jobs in every specialty and state. Visit today and Create Job Alerts, Manage Your Resume, and Apply for Jobs.

A Big Thank You To Our Sponsors
Top